← Patent-cliff monitor small molecule VERQUVO VERICIGUAT
Loss of exclusivity November 2032 latest FDA-listed patent expiry
Company MERCK SHARP AND DOHME LLC
Drug detail Brand name VERQUVO Active ingredient VERICIGUAT Strength 2.5MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval January 2021 Marketing status RX
Listed patents Patent Expires Type 9604948 November 2032 substance, product 9993476 May 2031 use U-3062 8921377 May 2031 use U-3062 11439642 May 2031 use U-3062 10736896 May 2031 substance, product 8420656 May 2031 substance, product
Regulatory exclusivity Code Expires D-198 January 2029 NCE January 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.